Philips creates first digital pathology lab; Stealthy Stanford startup raises $11.9M;

@FierceMedDev: ICYMI from FierceDiagnostics: CombiMatrix coasts toward growth with renewed sales push. Report | Follow @FierceMedDev

@StacyALawrence: Go big or go home: A call for FierceMedicalDevices' 2015 Fierce 15 nominations. ICYMI | Follow @StacyALawrence

@EmilyWFierce: Natera joins forces with University College London for lung cancer study. FierceDiagnostics story | Follow @EmilyWFierce

> Stealthy Stanford neuromodulation startup Nalu Medical raises $11.9 million in its first reported institutional round. SEC filing

> Royal Philips ($PHG) has built the first fully digital diagnostic capability for Dutch clinical pathology laboratory LabPON. More

> Sorin has launched FlexTherm--the latest heating and cooling system to integrate with its heart-lung machine for use during open-heart surgery that requires cardiopulmonary bypass. More

Biotech News

@FierceBiotech: 21st Century drug bill triggers a DC dust-up over relaxed development regs. Report | Follow @FierceBiotech

@JohnCFierce: EuroBiotech: KDEV halves portfolio value, U.K. life sci funding hits 10-year high, CF gene therapy on the block. Report | Follow @JohnCFierce

@DamianFierce: ICYMI: Patrick Soon-Shiong tacitly creates another company every time he does anything. NantKwest?! Release | Follow @DamianFierce

> Sanofi cozies up to top-tier labs with new R&D partnering effort. News

> Third Rock's GBT swings for a $115M IPO to push its pill for sickle cell. Article

> Woodford backs ReNeuron's $106M fundraise for cell therapy R&D. Report

Pharma News

@FiercePharma: ImmuCell boosts Q2 sales guidance as inventory management improves. FierceAnimalHealth article | Follow @FiercePharma

@EricPFierce: FDA says China staffer Dr. Lixia Wang was key to negotiating deal for more FDA inspection staff in China. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: AstraZeneca grabs $215M for GI drug rights in latest cash-generating deal. Article | Follow @CarlyHFierce

> Novartis' pay-for-performance Entresto plan has its critics--Express Scripts' Miller among them. Story

> U.K. cost gatekeeper changes its tune on Entyvio for Crohn's. More

> Fresenius companies fined £550,000 by U.K. court in patient death. News

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.